Pharmaceutical industry news
Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.
36,672 stories, page 170 of 612
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydrox...
Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source
Meeting of the Microbiome Subcommittee of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HH...
Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source
Determination That CABAZITAXEL (Cabazitaxel) Solution (Injection), 60 Milligrams/6 Milliliters (10 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA, Agency, or we) has determined that CABAZITAXEL (cabazitaxel)...
Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source
International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Et
The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunit...
Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source
Agency Information Collection Activities; Proposed Collection; Comment Request; Allegations of Regulatory Misconduct Voluntarily Submitted to the Center for Devices and Radiological Health
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on...
Federal RegisterOriginal source






